St Jude Medical (STJ) Stock Price, News & Analysis

Company Overview

St. Jude Medical, Inc. is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. The Company's product categories include tachycardia implantable cardioverter defibrillator systems; atrial fibrillation products (electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems); bradycardia pacemaker systems; vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography imaging products, vascular plugs, heart failure monitoring devices and other vascular accessories); structural heart products (heart valve replacement and repair products and structural heart defect devices); neuromodulation products, and Thoratec products.

Key Stats

• Today's Range: $80.82 to $80.82
• 50-Day Range: N/A
• 52-Week Range: $48.83 to $84.00
• Volume: N/A
• Average Volume: 8.54 million shs
• Market Capitalization: N/A
• P/E Ratio: 13.77
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

STJ Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of St Jude Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that St Jude Medical investors own include Bristol-Myers Squibb (BMY), Abbott Laboratories (ABT), Gilead Sciences (GILD), Eli Lilly and Company (LLY), Wheaton Precious Metals (WPM), Meta Platforms (META) and Johnson & Johnson (JNJ).

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: N/A
• Industry: N/A
• Sub-Industry: Health Care Equipment
• Current Symbol: NYSE:STJ
• CUSIP: 79084910
• CIK: 203077
• Web: www.sjm.com
• Phone: +1-651-7562000
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 13.77
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Optionable
• Beta: N/A